A Georgia man who alleges his heart attack was caused by his use of the prescription drug Adderall can keep his case in the Philadelphia Common Pleas Court because the manufacturer’s employees involved in the development, testing and marketing of Adderall are based in Pennsylvania, the state Superior Court ruled last week.
“There is no question that the central issue herein relates to [the manufacturer's] development, testing, and marketing of Adderall, and its knowledge of and warnings about the risks of heart attack from ingesting that drug,” Judge Mary Jane Bowes wrote for a three-judge panel that also included Judge Correale F. Stevens and Senior Judge James J. Fitzgerald III, a former Supreme Court justice. “The events relating to these activities were conducted by [the manufacturer's] employees in Pennsylvania.”
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
